References
- VeronesiUCascinelliNMarianiLTwenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancerN Engl J Med2002347161227123212393819
- van DongenJAVoogdACFentimanISLong-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trialJ Natl Cancer Inst200092141143115010904087
- JacobsonJADanforthDNCowanKHTen-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancerN Engl J Med1995332149079117877647
- PoggiMMDanforthDNSciutoLCEighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized TrialCancer200398469770212910512
- NeriAMarrelliDRossiSBreast cancer local recurrence: risk factors and prognostic relevance of early time to recurrenceWorld J Surg2007311364517180474
- ArvoldNDTaghianAGNiemierkoAAge, breast cancer subtype approximation, and local recurrence after breast-conserving therapyJ Clin Oncol201129293885389121900114
- BolletMASigal-ZafraniBMazeauVAge remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery firstRadiother Oncol200782327228017287037
- ChenWSonkeJJStroomJBartelinkHVerheijMGilhuijsKThe effect of age in breast conserving therapy: a retrospective analysis on pathology and clinical outcome dataRadiother Oncol2015114331432125640300
- XieZWangXLinHBreast-conserving therapy: a viable option for young women with early breast cancer – evidence from a prospective studyAnn Surg Oncol20142172188219624599412
- Martínez-RamosDFortea-SanchisCEscrig-SosJPrats-de PuigMQueralt-MartínRSalvador-SanchisJLLocal recurrence based on size after conservative surgery in breast cancer stage T1-T2: a population-based studyCir Cir2014823252261 Spanish25238466
- DominiciLSMittendorfEAYuTKBedrosianIImpact of breast cancer subtypes on local-regional outcomesCurr Breast Cancer Rep201022107113
- Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)DaviesCGodwinJRelevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trialsLancet2011378979377178421802721
- DowsettMCuzickJIngleJMeta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifenJ Clin Oncol201028350951819949017
- GrannVRTroxelABZojwallaNJJacobsonJSHershmanDNeugutAIHormone receptor status and survival in a population-based cohort of patients with breast carcinomaCancer2005103112241225115844176
- ParkCCMitsumoriMNixonAOutcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrenceJ Clin Oncol20001881668167510764427
- JobsenJJVan Der PalenJOngFMeerwaldtJHDifferences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapyActa Oncol200746217218017453365
- HoussamiNMacAskillPMarinovichMLMeta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapyEur J Cancer201046183219323220817513
- FreedmanGMLiTPolliLVLymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiationBreast J201218541541922776042
- CarrJAHavstadSZarboRJDivineGMackowiakPVelanovichVThe association of HER-2/neu amplification with breast cancer recurrenceArch Surg2000135121469147411115354
- AndrulisILBullSBBlacksteinMENeu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study GroupJ Clin Oncol1998164134013499552035
- RouanetPRogerPRousseauEHER2 overexpression a major risk factor for recurrence in pT1a-bN0M0 breast cancer: results from a French regional cohortCancer Med20143113414224407937